Add
SOMX to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| SOMX > SEC Filings for SOMX > Form 8-K on 31-Oct-2012 | All Recent SEC Filings |
31-Oct-2012
Results of Operations and Financial Condition, Financial Statements
On October 31, 2012, Somaxon Pharmaceuticals, Inc. issued a press release announcing its results of operations for the third quarter ended September 30, 2012. The full text of such press release is furnished as Exhibit 99.1 to this report.
In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Current Report on Form 8-K.
(d) Exhibits.
The following press release is furnished as an exhibit to this Current Report on Form 8-K pursuant to Item 2.02 and shall not be deemed to be "filed":
Exhibit No. Description
99.1 Press Release, dated October 31, 2012.
|
|